WB4-24 exhibited dose-dependent and specific anti-hypersensitive effects in acute and chronic inflammatory nociception induced by formalin, carrageenan, and CFA [31]
Medical Writing/Editorial Assistance The authors would like to thank Karen Nunley, PhD (Syneos Health) for medical writing assistance, and Raena Fernandes, MSc, ELS and Aruna Clemente, PhD, (both of Syneos Health) for editorial assistance
But its crucial to look past the hype and compare new, experimental substances like BPC-157 with established, evidence-backed treatments
If you're taking insulin or sulfonylureas alongside your GLP-1 medicine, your healthcare provider may need to adjust these doses to reduce the risk of hypoglycaemia, which can itself cause headaches